Envista is a global dental health company with more than 30 brands, approximately 12,000 employees, and annual revenues of around $2.5 billion. Its portfolio covers an estimated 90% of dentists' clinical needs and draws on more than 125 years of combined industry experience across its brands. The company operates in over 120 countries.
The business is organised into two segments. Specialty Products & Technologies encompasses dental implant systems, prosthetics, clear aligners, and orthodontic products. Equipment & Consumables covers digital imaging systems, dental practice equipment, restorative materials, and infection prevention products. Well-known brands within the portfolio include Nobel Biocare, Ormco, Implant Direct, DEXIS, Kerr, and Metrex.
Envista's stated strategic direction centres on digitising, personalising, and democratising oral care. Internally, the company operates through the Envista Business System (EBS), a structured methodology for continuous improvement. Core values include customer centricity, innovation, respect, and leadership.
